Valuation : Gedeon Richter

Market Cap 2,285B 7.3B 6.29B 5.96B 5.4B 10.13B 697B 10.18B 70.74B 27.2B 355B 27.42B 26.82B 1,121B P/E 2026 *
9.22x
P/E 2027 * 7.88x
Enterprise Value 2,023B 6.46B 5.57B 5.27B 4.78B 8.96B 617B 9.01B 62.61B 24.08B 314B 24.27B 23.74B 992B EV / Sales 2026 *
2.13x
EV / Sales 2027 * 1.84x
Free-Float
72.87%
Yield 2026 *
4.82%
Yield 2027 * 5.4%
3 years 23.55
Extreme 23.55
30.92
5 years 17.54
Extreme 17.54
30.92
10 years 17.54
Extreme 17.54
30.92
Manager TitleAgeSince
Chief Executive Officer 47 2017-10-31
Director of Finance/CFO - 2025-04-30
Chief Operating Officer - 2018-12-31
Director TitleAgeSince
Chairman 78 2016-12-31
Chairman 90 2024-02-29
Director/Board Member 65 2012-04-25
Change 5-day change 1-year change 3-year change Capi.($)
+24.45%-.--% - - 7.27B
-1.13%-3.11%+14.31%+61.84% 46.7B
-1.13%-5.78%+34.89%+111.91% 39.11B
+0.12%-0.08%+7.23%+78.04% 11.66B
-0.53%-1.37%-12.48%+9.51% 11.6B
-0.38%-2.26%+18.18%+136.36% 9.19B
+0.32%-2.26%+23.33%+33.23% 7.27B
-1.00%-5.25%+33.87%-18.63% 7.15B
+0.17%-0.74%+13.70%+198.32% 7.13B
-3.13%-4.30%-44.48%+13.47% 5.13B
Average +1.78%-3.09%+9.84%+69.34% 16.1B
Weighted average by Cap. +0.35%-3.63%+16.70%+76.79%

Financials

2026 *2027 *
Net sales 951B 3.04B 2.62B 2.48B 2.25B 4.22B 290B 4.24B 29.45B 11.32B 148B 11.41B 11.16B 467B 1,021B 3.26B 2.81B 2.66B 2.41B 4.52B 312B 4.55B 31.6B 12.15B 159B 12.25B 11.98B 501B
Net income 254B 812M 700M 663M 601M 1.13B 77.61B 1.13B 7.87B 3.03B 39.48B 3.05B 2.98B 125B 291B 928M 800M 757M 686M 1.29B 88.67B 1.29B 8.99B 3.46B 45.11B 3.49B 3.41B 143B
Net Debt -262B -838M -722M -684M -620M -1.16B -80.1B -1.17B -8.12B -3.12B -40.75B -3.15B -3.08B -129B -410B -1.31B -1.13B -1.07B -969M -1.82B -125B -1.83B -12.69B -4.88B -63.66B -4.92B -4.81B -201B
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
11,155
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12,530.00HUF
Average target price
13,214.57HUF
Spread / Average Target
+5.46%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!